Responses
Hemorrhagic Stroke
Original research
Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience
Compose a Response to This Article
Other responses
No responses have been published for this article.